cytosine has been researched along with Skin Diseases, Infectious in 5 studies
Skin Diseases, Infectious: Skin diseases caused by bacteria, fungi, parasites, or viruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The phosphonylmethoxyalkyl derivative (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) was evaluated for its in vivo efficacy in several model infections for herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) and thymidine kinase-deficient (TK-) HSV-1 in mice." | 7.68 | Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice. ( De Clercq, E; Holý, A, 1991) |
| "The phosphonylmethoxyalkyl derivative (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) was evaluated for its in vivo efficacy in several model infections for herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) and thymidine kinase-deficient (TK-) HSV-1 in mice." | 3.68 | Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice. ( De Clercq, E; Holý, A, 1991) |
| "The treatment of progressive vaccinia in individuals has involved antiviral drugs, such as cidofovir (CDV), brincidofovir, and/or tecovirimat, combined with vaccinia immune globulin (VIG)." | 1.42 | Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice. ( Dagley, A; Downs, B; Hagloch, J; Smee, DF; Tarbet, EB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smee, DF | 1 |
| Dagley, A | 1 |
| Downs, B | 1 |
| Hagloch, J | 1 |
| Tarbet, EB | 1 |
| Toro, JR | 1 |
| Sanchez, S | 1 |
| Turiansky, G | 1 |
| Blauvelt, A | 1 |
| Kremsdorf, D | 1 |
| Jablonska, S | 1 |
| Favre, M | 1 |
| Orth, G | 1 |
| Shelley, WB | 1 |
| Sica, PA | 1 |
| De Clercq, E | 1 |
| Holý, A | 1 |
1 review available for cytosine and Skin Diseases, Infectious
| Article | Year |
|---|---|
Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
Topics: Administration, Cutaneous; Administration, Topical; Antiviral Agents; Carcinoma in Situ; Carcinoma, | 2003 |
4 other studies available for cytosine and Skin Diseases, Infectious
| Article | Year |
|---|---|
Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice.
Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Dru | 2015 |
Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes.
Topics: Base Composition; Base Sequence; Cloning, Molecular; Cytosine; DNA Restriction Enzymes; DNA, Viral; | 1983 |
Disseminate sporotrichosis of skin and bone cured with 5-fluorocytosine: Photosensitivity as a complication.
Topics: Adult; Amphotericin B; Bone Diseases; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male | 1983 |
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.
Topics: Acyclovir; Animals; Antiviral Agents; Brain Diseases; Cidofovir; Cytosine; Herpes Simplex; Mice; Mic | 1991 |